Astellas Patient Assistance Program
The Astellas Patient Assistance Programa provides Myrbetriq® (mirabegron extended-release tablets) at no cost to patients who meet the program eligibility requirements. The PAP is not available for patients prescribed Myrbetriq® granules (mirabegron for extended-release oral suspension).
Myrbetriq Support Solutionsb can assess whether you are eligible for enrollment. For more information, contact us at 1-800-477-6472. We are available Monday–Friday, 9:00 am–8:00 pm ET.
You may be eligible if you meet the following criteria:
- Be an adult 18 years of age or older
- Be uninsured or have insurance that excludes coverage for Myrbetriq
- Have a verifiable shipping address within the United States
- Have been prescribed Myrbetriq for an FDA-approved indication
- Meet the program financial eligibility requirements
If you meet the program requirements, your healthcare provider can start the application process by submitting the Patient Enrollment Form that includes the necessary information for us to assess your eligibility.
Once you are approved for the Astellas Patient Assistance Program, we will notify both you and your healthcare provider that you have been enrolled. A supply of Myrbetriq will then be shipped directly to your home.
a The program is void where prohibited by law.
b Myrbetriq Support Solutions is a component of Astellas Pharma Support SolutionsSM.
Myrbetriq® is a registered trademark of Astellas Pharma Inc.